UMIN000048523Not yet recruiting
Effect of tofogliflozin on glycemic fluctuation in patients with type 2 diabetes with non-alcoholic fatty liver disease (NAFLD)
Minami Osaka HospitalUniversity Hospital Medical Information Networkdrug
VerifiedUniversity Hospital Medical Information Network
Study focus
- Disease/Condition
- type 2 diabetes
- Study type
- Interventional
- Intervention type
- drug
Sponsor & location
- Primary sponsor
- Minami Osaka Hospital
- Location
- Japan
Timeline & enrollment
- Phase
- N/A
- Start date
- Aug 04, 2022
- End date
- N/A
ICD-10 classifications
Type 2 diabetes mellitusType 2 diabetes mellitus without complicationsType 2 diabetes mellitus with unspecified complicationsType 2 diabetes mellitus with other specified complicationsType 2 diabetes mellitus with multiple complications
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000048523
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for UMIN000048523 through Pure Global AI's free database. This phase not specified trial is sponsored by Minami Osaka Hospital and is currently Not yet recruiting. The study focuses on type 2 diabetes.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.